Raw Peptide Co PE-22-28 10mg vialPE-22-28
    Performance & Recovery

    PE-22-28

    At a glance

    A synthetic peptide derived from spadin, studied in animal research for mood, stress resilience and nerve-cell growth.

    PE-22-28 is an experimental synthetic peptide derived from a region of the neurotrophic protein spadin, which has been investigated for its potential effects on mood regulation and neurological function. It is primarily studied for its interaction with TREK-1 potassium channels, which are involved in regulating neuronal excitability and responses to stress. By inhibiting TREK-1 activity, PE-22-28 has demonstrated antidepressant-like effects in preclinical research, attracting interest as a potential approach to treating depression and related mood disorders. Research has also explored its possible influence on neuroplasticity and brain signalling pathways associated with emotional wellbeing. However, most findings come from laboratory and animal studies, and there is insufficient high-quality human evidence to establish its effectiveness for depression, anxiety, or cognitive enhancement. PE-22-28 is not an approved medical treatment, and its optimal dosing, long-term safety, and potential side effects in humans remain unknown. Further clinical research is needed to determine its therapeutic potential.

    £35

    Order this product

    Message us on WhatsApp at 07361 793324 or email rawpeptides@outlook.com with the product name and quantity. We'll confirm payment and delivery by reply.

    Add a starter pack to any order for £10. Just mention it in your message.

    Sold for research use only. Not for human consumption. Not for veterinary use.

    Product details

    Purity

    99%+

    Size

    10mg

    Form

    Lyophilised Powder

    Testing

    On request

    • Over 99% purity
    • Sealed research vial
    • Boxed with blister pack
    • Store between 2°C and 8°C